【24h】

Slovenian Renal Replacement Therapy Registry: excerpts from the 2008 Annual Report.

机译:斯洛文尼亚肾脏替代疗法注册处:摘自2008年年度报告。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

This report provides a summary of the 2008 Slovenian Renal Replacement Therapy Registry Annual Report. Data on renal replacement therapy (RRT) were obtained from 20 dialysis centers and one transplant center, referring 31 December 2008, with 100% response rate to individual patient questionnaires. Slovenia has a population of approximately two million. The total number of patients treated by RRT was 1967, i.e. 968 per million of population (pmp), a 3.7% increase compared to 2007. In total, 1343 (68.3%) were treated by hemodialysis, 105 (5.3%) by peritoneal dialysis, and 519 (26.4%) had a functioning kidney graft. A total of 235 incident patients, 116 pmp (at day one), started RRT: their median age was 67 years, 61.8% were men, and 28% were diabetics. Regarding hemodialysis patients, 77% were dialyzed in hospital and 23% in private centers, 48% were treated with on-line hemodiafiltration and 74% with ultrapure dialysis fluid. The median weekly duration of hemodialysis was 13.5 hours, median dry body weight 68 kg, mean blood flow 283 +/- 51 mL/min, and 9.2% were dialyzed using a single-needle mode. Vascular access was provided by a native arteriovenous fistula in 82%, a polytetrafluoroethylene graft in 6%, and a catheter in 12%. The crude death rate was 12.4% in dialysis patients, 1.4% in transplant recipients, and 9.4% in all RRT patients (both dialysis and transplant, incident patients at day 1 included). The longest survival on RRT is 38 years (with hemodialysis only). Slovenia has been a member of Eurotransplant since 2000; 52 kidney transplantations were performed in 2008, all from deceased donors.
机译:本报告提供了2008斯洛文尼亚肾脏替代疗法注册管理机构年度报告的摘要。肾脏替代疗法(RRT)的数据来自2008年12月31日从20个透析中心和一个移植中心获得的数据,对单个患者问卷的答复率为100%。斯洛文尼亚的人口约为200万。 RRT治疗的患者总数为1967,即每百万人口968(pmp),比2007年增长了3.7%。血液透析治疗的总人数为1343(68.3%),腹膜透析治疗的总人数为105(5.3%) ,并且519(26.4%)的肾移植功能正常。共有235名事件患者(第一天为116 pmp)开始RRT:他们的中位年龄为67岁,男性为61.8%,糖尿病患者为28%。在血液透析患者中​​,有77%的患者在医院透析,在私人中心的透析率为23%,其中48%的患者接受了在线血液透析滤过,而74%的患者接受了超纯透析液。每周一次血液透析的中位时间为13.5小时,平均干体重为68千克,平均血流283 +/- 51毫升/分钟,而9.2%的患者采用单针模式透析。 82%的天然动静脉瘘,6%的聚四氟乙烯移植物和12%的导管提供了血管通路。透析患者的粗死亡率为12.4%,移植患者为1.4%,所有RRT患者为9.4%(包括透析和移植,包括第1天的事件患者)。 RRT的最长生存期为38年(仅血液透析)。自2000年以来,斯洛文尼亚一直是Eurotransplant的成员。 2008年进行了52次肾脏移植,全部来自已故的捐助者。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号